Axcan Photofrin approval
Executive Summary
Axcan Photofrin (porfimer sodium) approved by FDA Aug. 1 for ablation of high-grade dysplasia in Barrett's esophagus patients. Approval of the new indication for the photodynamic therapy follows recommendations of Gastrointestinal Drugs Advisory Committee meeting June 26 (1"The Pink Sheet" June 30, 2003, p. 18)...